FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3080476633> ?p ?o ?g. }

• W3080476633 endingPage "2047" @default.
• W3080476633 startingPage "2037" @default.
• W3080476633 abstract "A substantial proportion of patients with adult-onset diabetes share features of both type 1 diabetes (T1D) and type 2 diabetes (T2D). These individuals, at diagnosis, clinically resemble T2D patients by not requiring insulin treatment, yet they have immunogenetic markers associated with T1D. Such a slowly evolving form of autoimmune diabetes, described as latent autoimmune diabetes of adults (LADA), accounts for 2–12% of all patients with adult-onset diabetes, though they show considerable variability according to their demographics and mode of ascertainment. While therapeutic strategies aim for metabolic control and preservation of residual insulin secretory capacity, endotype heterogeneity within LADA implies a personalized approach to treatment. Faced with a paucity of large-scale clinical trials in LADA, an expert panel reviewed data and delineated one therapeutic approach. Building on the 2020 American Diabetes Association (ADA)/European Association for the Study of Diabetes (EASD) consensus for T2D and heterogeneity within autoimmune diabetes, we propose “deviations” for LADA from those guidelines. Within LADA, C-peptide values, proxy for β-cell function, drive therapeutic decisions. Three broad categories of random C-peptide levels were introduced by the panel: 1) C-peptide levels &lt;0.3 nmol/L: a multiple-insulin regimen recommended as for T1D; 2) C-peptide values ≥0.3 and ≤0.7 nmol/L: defined by the panel as a “gray area” in which a modified ADA/EASD algorithm for T2D is recommended; consider insulin in combination with other therapies to modulate β-cell failure and limit diabetic complications; 3) C-peptide values &gt;0.7 nmol/L: suggests a modified ADA/EASD algorithm as for T2D but allowing for the potentially progressive nature of LADA by monitoring C-peptide to adjust treatment. The panel concluded by advising general screening for LADA in newly diagnosed non–insulin-requiring diabetes and, importantly, that large randomized clinical trials are warranted." @default.
• W3080476633 created "2020-09-01" @default.
• W3080476633 creator A5012291664 @default.
• W3080476633 creator A5016239812 @default.
• W3080476633 creator A5039395009 @default.
• W3080476633 creator A5047062221 @default.
• W3080476633 creator A5049407947 @default.
• W3080476633 creator A5061973111 @default.
• W3080476633 creator A5087265840 @default.
• W3080476633 date "2020-08-26" @default.
• W3080476633 modified "2023-10-16" @default.
• W3080476633 title "Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel" @default.
• W3080476633 cites W1050125050 @default.
• W3080476633 cites W1493207176 @default.
• W3080476633 cites W1531029954 @default.
• W3080476633 cites W1531291756 @default.
• W3080476633 cites W1917326214 @default.
• W3080476633 cites W1968145935 @default.
• W3080476633 cites W1969080742 @default.
• W3080476633 cites W1972182005 @default.
• W3080476633 cites W1977415491 @default.
• W3080476633 cites W1978466632 @default.
• W3080476633 cites W1981490811 @default.
• W3080476633 cites W1982948566 @default.
• W3080476633 cites W1988519907 @default.
• W3080476633 cites W1991909333 @default.
• W3080476633 cites W1992251328 @default.
• W3080476633 cites W1997439620 @default.
• W3080476633 cites W2001072123 @default.
• W3080476633 cites W2005843003 @default.
• W3080476633 cites W2008443993 @default.
• W3080476633 cites W2021841170 @default.
• W3080476633 cites W2035576179 @default.
• W3080476633 cites W2042850859 @default.
• W3080476633 cites W2045385822 @default.
• W3080476633 cites W2047627973 @default.
• W3080476633 cites W2051964614 @default.
• W3080476633 cites W2052838451 @default.
• W3080476633 cites W2067644596 @default.
• W3080476633 cites W2069486925 @default.
• W3080476633 cites W2080986637 @default.
• W3080476633 cites W2098739800 @default.
• W3080476633 cites W2099670937 @default.
• W3080476633 cites W2099818969 @default.
• W3080476633 cites W2099852272 @default.
• W3080476633 cites W2100086068 @default.
• W3080476633 cites W2103769722 @default.
• W3080476633 cites W2110009838 @default.
• W3080476633 cites W2111389753 @default.
• W3080476633 cites W2111905905 @default.
• W3080476633 cites W2115641328 @default.
• W3080476633 cites W2129181935 @default.
• W3080476633 cites W2137638424 @default.
• W3080476633 cites W2138663588 @default.
• W3080476633 cites W2140740027 @default.
• W3080476633 cites W2141240964 @default.
• W3080476633 cites W2152656099 @default.
• W3080476633 cites W2154711384 @default.
• W3080476633 cites W2162172210 @default.
• W3080476633 cites W2164368465 @default.
• W3080476633 cites W2175219657 @default.
• W3080476633 cites W2267284381 @default.
• W3080476633 cites W2341387423 @default.
• W3080476633 cites W2510668456 @default.
• W3080476633 cites W2587394174 @default.
• W3080476633 cites W2742109489 @default.
• W3080476633 cites W2752569040 @default.
• W3080476633 cites W2754426117 @default.
• W3080476633 cites W2755899227 @default.
• W3080476633 cites W2791143589 @default.
• W3080476633 cites W2795905061 @default.
• W3080476633 cites W2809590939 @default.
• W3080476633 cites W2883718598 @default.
• W3080476633 cites W2884380775 @default.
• W3080476633 cites W2889482220 @default.
• W3080476633 cites W2893903094 @default.
• W3080476633 cites W2894624538 @default.
• W3080476633 cites W2896925990 @default.
• W3080476633 cites W2901474773 @default.
• W3080476633 cites W2906976213 @default.
• W3080476633 cites W2913123058 @default.
• W3080476633 cites W2923480039 @default.
• W3080476633 cites W2926390054 @default.
• W3080476633 cites W2932901353 @default.
• W3080476633 cites W2945252747 @default.
• W3080476633 cites W2946601379 @default.
• W3080476633 cites W2946960604 @default.
• W3080476633 cites W2947074868 @default.
• W3080476633 cites W2948025279 @default.
• W3080476633 cites W2967824496 @default.
• W3080476633 cites W2969557623 @default.
• W3080476633 cites W2977126534 @default.
• W3080476633 cites W2989794873 @default.
• W3080476633 cites W2991077754 @default.
• W3080476633 cites W2996554586 @default.
• W3080476633 cites W2996735054 @default.
• W3080476633 cites W3005511727 @default.
• W3080476633 cites W3005666168 @default.

• next